Smoking Cessation & Opioid Dependence Treatment Integration

Completed · Phase 2/Phase 3

Conditions studied: Smoking Cessation, Opioid Related Disorders

In brief

The primary purpose of this study was to examine the feasibility of integrating a smoking cessation intervention for cigarette smokers enrolled in an outpatient program for opioid dependence. The secondary purpose was to compare treatment effects as a function of phase in the outpatient program: 0-90 days (weekly attendance), 90 days-1 year (biweekly attendance), and more than 1 year (monthly attendance).

Key facts

Study ID
NCT02854800
Run by
West Virginia University
People needed
74
Starts
2016-07-08
Expected to finish
2017-04-10
Last updated by the study team
2020-08-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.